Nasdaq Hearings Panel grants SCWorx reconsideration, approves continued Nasdaq listing; trading reinstatement pending

SCWorx Corp.

Nasdaq Hearings Panel on Oct 2, 2026 granted SCWorx reconsideration, finding compliance with Rules 5550(a)(2) and 5550(a)(4) and approving continued listing.
Trading on Nasdaq has been suspended since April 14, 2026; reinstatement date to be scheduled after SCWorx files Nasdaq's reinstatement form on Oct 5, 2026.
Sept 16, 2026 private placement of 350,000 shares and warrants raised publicly held shares to 549,092 as of Sept 17, 2026; aggregate subscription amount $938,000.
Purchasers delivered waivers on/after Sept 29, 2026, agreeing not to exercise Section 4.20 termination rights based on the Sept 17 delisting decision, with no consideration.
Panel imposed one-year Discretionary Panel Monitor ending Oct 2, 2027 and monthly public float reports through Oct 5, 2027; CEO Tim Hannibal and CFO Chris Kohler cited.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.